Cardiac toxicity in patients with lung cancer receiving thoracic radiotherapy and immunotherapy

BACKGROUND: Immune checkpoint inhibitors (ICIs) are used to treat locally-advanced and metastatic lung cancer, which can lead to severe immunogenic-related cardiotoxicities. We assessed the risk of cardiotoxicity in ICI-treated lung cancer patients with or without cardiac radiation from thoracic rad...

Descripción completa

Detalles Bibliográficos
Autores principales: Son, Christine, Moey, Melissa Y. Y., Walker, Paul R., Naqash, Abdul R., Peach, Matthew Sean, Ju, Andrew W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868592/
https://www.ncbi.nlm.nih.gov/pubmed/36698405
http://dx.doi.org/10.3389/fonc.2022.1025455

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868592/
https://www.ncbi.nlm.nih.gov/pubmed/36698405
http://dx.doi.org/10.3389/fonc.2022.1025455

Ejemplares similares